BioAtla, Inc. - Common Stocks, par value $0,0001 per share (BCAB)
CUSIP: 09077B104
Q2 2025 13F Holders as of 30 Jun 2025
- Type / Class
- Equity / Common Stocks, par value $0,0001 per share
- Shares outstanding
- 58,548,563
- Total 13F shares
- 13,168,921
- Share change
- -537,668
- Total reported value
- $5,214,805
- Put/Call ratio
- 0%
- Price per share
- $0.40
- Number of holders
- 39
- Value change
- -$178,456
- Number of buys
- 13
- Number of sells
- 18
Quarterly Holders Quick Answers
What is CUSIP 09077B104?
CUSIP 09077B104 identifies BCAB - BioAtla, Inc. - Common Stocks, par value $0,0001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 09077B104:
Top shareholders of BCAB - BioAtla, Inc. - Common Stocks, par value $0,0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Guy Levy |
3/4/5
|
Former Director |
—
class O/S missing
|
1,130,688
|
$2,781,493 | — | 16 Jun 2022 | |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC |
13D/G
|
— |
7.7%
|
4,839,579
|
$2,129,415 | -$1,104,235 | 31 Mar 2025 | |
| ACORN BIOVENTURES, L.P. |
13D/G
|
Anders Hove |
8.3%
|
4,835,111
|
$2,127,449 | $0 | 15 May 2025 | |
| Jay M. Short PhD |
13D/G
|
Jay M. Short |
6.6%
|
3,865,646
|
$1,700,884 | $0 | 31 Dec 2024 | |
| ACORN CAPITAL ADVISORS, LLC |
13F
|
Company |
6.9%
|
4,032,046
|
$1,411,216 | — | 31 Mar 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
3.1%
|
1,818,002
|
$630,846 | — | 31 Mar 2025 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
2.9%
|
1,690,110
|
$585,000 | — | 31 Mar 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13D/G
13F
|
Company |
1.9%
|
1,095,606
|
$482,067 | $0 | 31 Dec 2024 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
2.3%
|
1,374,076
|
$476,530 | — | 31 Mar 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
1.3%
|
744,834
|
$258,308 | — | 31 Mar 2025 | |
| MORGAN STANLEY |
13F
|
Company |
1%
|
595,587
|
$206,550 | — | 31 Mar 2025 | |
| BlackRock, Inc. |
13F
|
Company |
1%
|
593,897
|
$205,963 | — | 31 Mar 2025 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.9%
|
525,353
|
$183,874 | — | 31 Mar 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.82%
|
479,268
|
$166,252 | — | 31 Mar 2025 | |
| Scott Andrew Smith |
3/4/5
|
Director |
0.55%
|
321,550
|
$125,404 | — | 18 Jun 2025 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.44%
|
260,247
|
$90,254 | — | 31 Mar 2025 | |
| GSA CAPITAL PARTNERS LLP |
13F
|
Company |
0.4%
|
233,156
|
$81,000 | — | 31 Mar 2025 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.32%
|
188,900
|
$65,511 | — | 31 Mar 2025 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.32%
|
188,526
|
$65,381 | — | 31 Mar 2025 | |
| STATE STREET CORP |
13F
|
Company |
0.26%
|
151,377
|
$52,498 | — | 31 Mar 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.17%
|
100,828
|
$34,967 | — | 31 Mar 2025 | |
| Lawrence Steinman |
3/4/5
|
Director |
0.13%
|
78,459
|
$30,599 | — | 18 Jun 2025 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.15%
|
86,335
|
$30,216 | — | 31 Mar 2025 | |
| Mary Ann Gray |
3/4/5
|
Director |
0.13%
|
77,397
|
$30,184 | — | 18 Jun 2025 | |
| Woodline Partners LP |
13F
|
Company |
0.13%
|
76,324
|
$26,469 | — | 31 Mar 2025 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.12%
|
72,320
|
$25,081 | — | 31 Mar 2025 | |
| Eddie Williams |
3/4/5
|
Director |
0.1%
|
60,200
|
$23,478 | — | 18 Jun 2025 | |
| Sylvia McBrinn |
3/4/5
|
Director |
0.1%
|
59,125
|
$23,058 | — | 18 Jun 2025 | |
| PVG ASSET MANAGEMENT CORP |
13F
|
Company |
0.11%
|
65,000
|
$22,542 | — | 31 Mar 2025 | |
| Susan Moran |
3/4/5
|
Director |
0.09%
|
52,307
|
$20,399 | — | 18 Jun 2025 | |
| UBS Group AG |
13F
|
Company |
0.08%
|
48,363
|
$16,782 | — | 31 Mar 2025 | |
| Magnus Financial Group LLC |
13F
|
Company |
0.08%
|
47,232
|
$16,380 | — | 31 Mar 2025 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.06%
|
33,713
|
$11,692 | — | 31 Mar 2025 | |
| COLUMBIA ADVISORY PARTNERS LLC |
13F
|
Company |
0.04%
|
26,070
|
$9,041 | — | 31 Mar 2025 | |
| COMMONWEALTH EQUITY SERVICES, LLC |
13F
|
Company |
0.04%
|
25,300
|
$9,000 | — | 31 Mar 2025 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0.04%
|
21,224
|
$7,360 | — | 31 Mar 2025 | |
| Global Wealth Strategies & Associates |
13F
|
Company |
0.02%
|
13,769
|
$4,775 | — | 31 Mar 2025 | |
| HighTower Advisors, LLC |
13F
|
Company |
0.02%
|
13,000
|
$4,508 | — | 31 Mar 2025 | |
| R Squared Ltd |
13F
|
Company |
0.02%
|
11,710
|
$4,061 | — | 31 Mar 2025 | |
| MAI Capital Management |
13F
|
Company |
0.02%
|
9,747
|
$3,381 | — | 31 Mar 2025 | |
| Twin Lakes Capital Management, LLC |
13F
|
Company |
0.02%
|
9,000
|
$3,121 | — | 31 Mar 2025 | |
| SIMPLEX TRADING, LLC |
13F
|
Company |
0.02%
|
9,463
|
$3,000 | — | 31 Mar 2025 | |
| Flaharty Asset Management, LLC |
13F
|
Company |
0.01%
|
4,150
|
$1,439 | — | 31 Mar 2025 | |
| SBI Securities Co., Ltd. |
13F
|
Company |
0.01%
|
4,115
|
$1,427 | — | 31 Mar 2025 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
0%
|
2,027
|
$703 | — | 31 Mar 2025 | |
| ARCADIA INVESTMENT MANAGEMENT CORP/MI |
13F
|
Company |
0%
|
1,403
|
$487 | — | 31 Mar 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
1,277
|
$443 | — | 31 Mar 2025 | |
| CIBC Private Wealth Group LLC |
13F
|
Company |
0%
|
1,290
|
$344 | — | 31 Mar 2025 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0%
|
472
|
$164 | — | 31 Mar 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
417
|
$145 | — | 31 Mar 2025 |
Institutional Holders of BioAtla, Inc. - Common Stocks, par value $0,0001 per share (BCAB) as of Q2 2025
As of 30 Jun 2025,
BioAtla, Inc. - Common Stocks, par value $0,0001 per share (BCAB) was held by
39 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
13,168,921 shares.
The largest 10 holders included
ACORN CAPITAL ADVISORS, LLC, VANGUARD GROUP INC, ACADIAN ASSET MANAGEMENT LLC, TANG CAPITAL MANAGEMENT LLC, RENAISSANCE TECHNOLOGIES LLC, DEUTSCHE BANK AG\, GEODE CAPITAL MANAGEMENT, LLC, BlackRock, Inc., MORGAN STANLEY, and ADAR1 Capital Management, LLC.
This page lists
39
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
40
Q2 2025 holders
39
Holder diff
-1
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 Value $ | Q2 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.